InvestorsHub Logo

sox040713

09/20/17 6:54 PM

#197679 RE: scottsmith #197674

I disagree. Phase 1 took a long time was a combination of Dana-Farber being slow and K being safe. After Phase 1 was completed in February 2016, K-OC Phase 2a started one year later. What do you think IPIX could have done differently to have K approved by now?

I also believe ipix managerial incompetence is to blame for K not yet being available to those that most need it.

Jhawker

09/20/17 7:07 PM

#197688 RE: scottsmith #197674

No your wrong. They have done a great job of moving the science forward with minimal dilution.

JTORENCE

09/20/17 8:11 PM

#197703 RE: scottsmith #197674

scottsmith and it won't be available for at least 5 years. Cancer treatment trials take big bucks and years to complete. We are not talking about "A" hole inflammation or skin rashes, but a dreaded disease that kills thousands.. Whole different ball game.

nerby

09/20/17 9:15 PM

#197705 RE: scottsmith #197674

I'm just catching up. Read this about Kevetrin and Krishna and then had a look at how many replies I might have to plow through going forward before a late dinner, and overall it was less than I expected, but the day is young and I'm hungry. I just happened to glance up recently and saw that someone with a name like scottsmith is now a moderator, and I was like, whoa.